Research Analysts Offer Predictions for UAMY FY2025 Earnings

United States Antimony Co. (NYSE:UAMY) – Equities research analysts at B. Riley decreased their FY2025 earnings per share estimates for United States Antimony in a note issued to investors on Wednesday, August 13th. B. Riley analyst N. Giles now expects that the company will post earnings per share of $0.05 for the year, down from their previous estimate of $0.06. The consensus estimate for United States Antimony’s current full-year earnings is ($0.01) per share. B. Riley also issued estimates for United States Antimony’s Q1 2026 earnings at $0.03 EPS, Q2 2026 earnings at $0.05 EPS, Q3 2026 earnings at $0.07 EPS, Q4 2026 earnings at $0.08 EPS and FY2027 earnings at $0.62 EPS.

Several other research firms have also issued reports on UAMY. D. Boral Capital reissued a “buy” rating and set a $5.00 price objective on shares of United States Antimony in a research note on Thursday. D Boral Capital raised United States Antimony to a “strong-buy” rating in a research note on Wednesday, April 23rd. Wall Street Zen lowered United States Antimony from a “hold” rating to a “sell” rating in a research note on Thursday, May 15th. Finally, HC Wainwright reaffirmed a “buy” rating and set a $4.50 price target on shares of United States Antimony in a research note on Wednesday. One analyst has rated the stock with a sell rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $3.38.

United States Antimony Price Performance

NYSE:UAMY opened at $4.13 on Thursday. The firm has a market capitalization of $491.89 million, a price-to-earnings ratio of -103.25 and a beta of 0.11. United States Antimony has a 52-week low of $0.40 and a 52-week high of $4.19. The stock has a fifty day moving average of $3.05 and a 200 day moving average of $2.56. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.84 and a current ratio of 6.24.

Institutional Investors Weigh In On United States Antimony

A number of hedge funds and other institutional investors have recently modified their holdings of UAMY. Raymond James Financial Inc. bought a new stake in shares of United States Antimony in the 2nd quarter valued at about $33,000. Cetera Investment Advisers bought a new stake in shares of United States Antimony in the 4th quarter valued at about $40,000. ProShare Advisors LLC bought a new stake in shares of United States Antimony in the 2nd quarter valued at about $41,000. Penbrook Management LLC bought a new stake in shares of United States Antimony in the 2nd quarter valued at about $44,000. Finally, Tower Research Capital LLC TRC lifted its stake in shares of United States Antimony by 2,205.1% in the 4th quarter. Tower Research Capital LLC TRC now owns 26,716 shares of the company’s stock valued at $47,000 after acquiring an additional 25,557 shares during the last quarter. Institutional investors own 9.49% of the company’s stock.

United States Antimony Company Profile

United States Antimony Corporation produces and sells antimony, silver, gold, precious metals, and zeolite products in the United States, and Canada. It operates through Antimony, Zeolite, and Precious Metals segments. The company offers antimony oxide that is primarily used in conjunction with a halogen to form a synergistic flame retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings, and paper, as well as color fastener in paints and as a phosphorescent agent in fluorescent light bulbs; antimony trisulfide used as a primer in ammunition; and antimony metal for use in bearings, storage batteries, and ordnance.